What's in Yooyoung Pharmaceutical Co., Ltd.'s pipeline?

Yooyoung Pharmaceutical Co., Ltd. has 10 drugs in our index: 0 marketed, 0 filed, 5 in Phase 3, 0 in Phase 2, 5 in Phase 1.

Which companies overlap with Yooyoung Pharmaceutical Co., Ltd.'s portfolio?

Top competitors by shared drug class: ADvantage Therapeutics, AJU Pharm Co., Ltd., AO GENERIUM, Abbott, AceLink Therapeutics, Inc..

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/yooyoung-pharmaceutical-co-ltd.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-16 · How we verify

Yooyoung Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Yooyoung Pharmaceutical Co., Ltd. pipeline: 0 marketed, 0 filed, 5 Phase 3, 0 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

0 marketed 0 filed 5 Phase 3 0 Phase 2 5 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Active comparator: Synovian Inj.	Active comparator: Synovian Inj.	phase 3	Viscosupplement (hyaluronic acid)	Synovial fluid replacement; hyaluronic acid	Orthopedics / Rheumatology
YYC506	YYC506	phase 3	SGLT2 inhibitor	SGLT2	Diabetes
Simdax	Simdax	phase 3		ATP-sensitive inward rectifier potassium channel 8, ATP-sensitive inward rectifier potassium channel 11, Troponin C, slow skeletal and cardiac muscles	Cardiovascular
YYC301-1 & YYC301-2 & YYC301-3	YYC301-1 & YYC301-2 & YYC301-3	phase 3
YYC405-T	YYC405-T	phase 3	SGLT2 inhibitor	SGLT2	Diabetes

Therapeutic area mix

Diabetes · 2
Cardiovascular · 1
Orthopedics / Rheumatology · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

ADvantage Therapeutics · 1 shared drug class
AJU Pharm Co., Ltd. · 1 shared drug class
AO GENERIUM · 1 shared drug class
Abbott · 1 shared drug class
AceLink Therapeutics, Inc. · 1 shared drug class
Ache Laboratorios Farmaceuticos S.A. · 1 shared drug class
Aciex Therapeutics, Inc. · 1 shared drug class
3D Medicines (Beijing) Co., Ltd. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for Yooyoung Pharmaceutical Co., Ltd.:

Cite this brief

Drug Landscape (2026). Yooyoung Pharmaceutical Co., Ltd. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/yooyoung-pharmaceutical-co-ltd. Accessed 2026-05-16.